Matches in Nanopublications for { ?s ?p "DDI between Insulin Lispro and Losartan - Concomitant therapy with angiotensin II receptor blockers may increase the blood-glucose-lowering effect of insulin lispro and thus the chance of hypoglycemia should be monitored closely. [drugbank_resource:DB00046_DB00678]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00046_DB00678 label "DDI between Insulin Lispro and Losartan - Concomitant therapy with angiotensin II receptor blockers may increase the blood-glucose-lowering effect of insulin lispro and thus the chance of hypoglycemia should be monitored closely. [drugbank_resource:DB00046_DB00678]" assertion.